Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has approved, after priority review, a new non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV-1 infected adults who have failed other antiretroviral agents.

Etravirine Tablets (Intelence™)